Cardiac Resynchronization Therapy
With cumulated knowledge and clinical trial experience in the last decade, the management of HF patients by CRT is rapidly evolving. Apart from updates in treatment guideline, a large number of current trials are ongoing to address unresolved issues of CRT. These concerted efforts will shape the future of HF device therapy leading to a boarder spectrum of patient selection, a high implantation success rate as well as better treatment response.
Conclusion
With cumulated knowledge and clinical trial experience in the last decade, the management of HF patients by CRT is rapidly evolving. Apart from updates in treatment guideline, a large number of current trials are ongoing to address unresolved issues of CRT. These concerted efforts will shape the future of HF device therapy leading to a boarder spectrum of patient selection, a high implantation success rate as well as better treatment response.
SHARE
